Catalyst
Slingshot members are tracking this event:
Phase 1b/2a of VBI Vaccines'(VBIV) BRII-179 (VBI-2601) in Hepatitis B -Boosting of hepatitis B surface antigen antibodies data from the high-dose cohorts expected in 1Q 2021
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| VBIV | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 23, 2021
Occurred Source:
https://www.vbivaccines.com/press-releases/international-liver-congress-2021/
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Brii-179, Phase 1b/2a, Vbi-2601, Hepatitis B
